Marblehead Medical, LLC

Marblehead Medical, LLC specializes in intravascular occluding balloon catheters designed for image-guided procedures. These devices are specifically engineered for controlled occlusion or dilation within blood vessels, often used in targeted vascular interventions where precision is critical. The company’s focus is on Class II devices, which are regulated under stricter standards due to their role in procedures requiring careful monitoring and safety.

Marblehead Medical, LLC is headquartered in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations. The FDA’s oversight includes mandatory registration in the 510(k) and Unique Device Identifier (UDI) databases, ensuring transparency and traceability for Class II devices like their intravascular occluding balloon catheters, which require pre-market clearance before commercialization.

Marblehead Medical’s devices are listed in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. The 510(k) process demonstrates that the company’s devices meet FDA standards for safety and effectiveness by showing substantial equivalence to a legally marketed predicate device. The UDI system ensures standardized identification of devices, improving tracking, recall management, and post-market surveillance—critical for Class II devices, which carry moderate risks and require rigorous monitoring.

Marblehead Medical’s intravascular occluding balloon catheters fall under FDA Class II classification. This classification indicates that while the devices are not as high-risk as Class III (e.g., implants or life-support systems), they still require special controls beyond general controls to ensure safety and performance. Class II devices undergo pre-market notification (510(k)) reviews and must comply with additional labeling, manufacturing, and post-market reporting requirements to mitigate potential risks during image-guided vascular procedures.